Mar 06, 2023 / 05:50PM GMT
Tyler Martin Van Buren - Cowen and Company, LLC, Research Division - MD & Senior Equity Research Analyst
Good afternoon, everyone. I'm Tyler Van Buren here, Senior Biotech Analyst at TD Cowen. Thank you very much for joining us for TD Cowen's 43rd Annual Healthcare Conference. For our next session, very pleased to have a fireside chat with Regeneron. And it's my pleasure to introduce Marion McCourt, Executive Vice President of Commercial; and Ryan Crowe, Vice President and Head of Investor Relations. Marion and Ryan, thank you very much for being here.
Ryan Crowe - Regeneron Pharmaceuticals, Inc. - VP of IR
Thank you, Tyler, and thanks for hosting us here at the TD Cowen Conference. Before we get started, I just wanted to remind you that remarks made today may include forward-looking statements about Regeneron. And each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in such statements. A description of material risks and uncertainties can be found in
Regeneron Pharmaceuticals Inc at Cowen Health Care Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers